Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H T Enterline

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
American Journal of Clinical Oncology|August 1, 1982
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomasE C Borden, A Ash, H T Enterline, et al.
Cancer|September 1, 1974
Lobular carcinoma in situ of the breast. Long-term followupJ E Wheeler, H T Enterline, J M Roseman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomasE C Borden, D A Amato, C Rosenbaum, et al.
Investigational New Drugs|January 1, 1985
Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesotheliomaD A Amato, E C Borden, M Shiraki, et al.
Cancer|July 15, 1989
Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experienceM Shiraki, H T Enterline, J J Brooks, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
American Journal of Clinical Oncology|August 1, 1982
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomasE C Borden, A Ash, H T Enterline, et al.
Cancer|September 1, 1974
Lobular carcinoma in situ of the breast. Long-term followupJ E Wheeler, H T Enterline, J M Roseman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomasE C Borden, D A Amato, C Rosenbaum, et al.
Investigational New Drugs|January 1, 1985
Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesotheliomaD A Amato, E C Borden, M Shiraki, et al.
Cancer|July 15, 1989
Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experienceM Shiraki, H T Enterline, J J Brooks, et al.
Pageof 4